Establishes "Equitable Drug Pricing and Patient Access Act."

This bill, S 2621, establishes the "Equitable Drug Pricing and Patient Access Act" to set minimum reimbursement rates for pharmacies providing prescription drugs to Medicaid beneficiaries in New Jersey. It mandates that pharmacies receive at least the national average drug acquisition cost plus a $10.92 dispensing fee, regardless of whether services are delivered through Medicaid’s fee-for-service or managed care systems. The bill requires Medicaid managed care organizations to include pharmacy choice as a mandatory benefit, ensuring enrollees can select any qualified pharmacy and preventing exclusion of pharmacies based on cost or other criteria. Additionally, it directs the State Auditor to audit pharmacy pricing practices and fund flows within Medicaid to identify potential state savings.